130 related articles for article (PubMed ID: 12023957)
1. Refractory skin injury in complex knock-out mice expressing only the GM3 ganglioside.
Inoue M; Fujii Y; Furukawa K; Okada M; Okumura K; Hayakawa T; Furukawa K; Sugiura Y
J Biol Chem; 2002 Aug; 277(33):29881-8. PubMed ID: 12023957
[TBL] [Abstract][Full Text] [Related]
2. Reduced motor and sensory functions and emotional response in GM3-only mice: emergence from early stage of life and exacerbation with aging.
Tajima O; Egashira N; Ohmi Y; Fukue Y; Mishima K; Iwasaki K; Fujiwara M; Inokuchi J; Sugiura Y; Furukawa K; Furukawa K
Behav Brain Res; 2009 Mar; 198(1):74-82. PubMed ID: 19013484
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular synaptic transmission in aged ganglioside-deficient mice.
Zitman FM; Todorov B; Verschuuren JJ; Jacobs BC; Furukawa K; Furukawa K; Willison HJ; Plomp JJ
Neurobiol Aging; 2011 Jan; 32(1):157-67. PubMed ID: 19233512
[TBL] [Abstract][Full Text] [Related]
4. A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice.
Chiavegatto S; Sun J; Nelson RJ; Schnaar RL
Exp Neurol; 2000 Dec; 166(2):227-34. PubMed ID: 11085888
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GM3 is essential for the structural integrity and function of cochlear hair cells.
Yoshikawa M; Go S; Suzuki S; Suzuki A; Katori Y; Morlet T; Gottlieb SM; Fujiwara M; Iwasaki K; Strauss KA; Inokuchi J
Hum Mol Genet; 2015 May; 24(10):2796-807. PubMed ID: 25652401
[TBL] [Abstract][Full Text] [Related]
6. Neuronally expressed a-series gangliosides are sufficient to prevent the lethal age-dependent phenotype in GM3-only expressing mice.
McGonigal R; Barrie JA; Yao D; Black LE; McLaughlin M; Willison HJ
J Neurochem; 2021 Jul; 158(2):217-232. PubMed ID: 33864399
[TBL] [Abstract][Full Text] [Related]
7. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures.
Kawai H; Allende ML; Wada R; Kono M; Sango K; Deng C; Miyakawa T; Crawley JN; Werth N; Bierfreund U; Sandhoff K; Proia RL
J Biol Chem; 2001 Mar; 276(10):6885-8. PubMed ID: 11133999
[TBL] [Abstract][Full Text] [Related]
8. Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I).
Kreutz F; dos Santos Petry F; Camassola M; Schein V; Guma FC; Nardi NB; Trindade VM
Gene; 2013 Sep; 527(1):109-14. PubMed ID: 23774686
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside GM3 synthase depletion reverses neuropathic pain and small fiber neuropathy in diet-induced diabetic mice.
Menichella DM; Jayaraj ND; Wilson HM; Ren D; Flood K; Wang XQ; Shum A; Miller RJ; Paller AS
Mol Pain; 2016; 12():. PubMed ID: 27590073
[TBL] [Abstract][Full Text] [Related]
10. Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion.
Allende ML; Li J; Darling DS; Worth CA; Young WW
Glycobiology; 2000 Oct; 10(10):1025-32. PubMed ID: 11030748
[TBL] [Abstract][Full Text] [Related]
11. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions.
Yamashita T; Wu YP; Sandhoff R; Werth N; Mizukami H; Ellis JM; Dupree JL; Geyer R; Sandhoff K; Proia RL
Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2725-30. PubMed ID: 15710896
[TBL] [Abstract][Full Text] [Related]
12. Diseases of ganglioside biosynthesis: An expanding group of congenital disorders of glycosylation.
Trinchera M; Parini R; Indellicato R; Domenighini R; dall'Olio F
Mol Genet Metab; 2018 Aug; 124(4):230-237. PubMed ID: 29983310
[TBL] [Abstract][Full Text] [Related]
13. Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis21.
Furukawa K; Aixinjueluo W; Kasama T; Ohkawa Y; Yoshihara M; Ohmi Y; Tajima O; Suzumura A; Kittaka D; Furukawa K
J Neurochem; 2008 May; 105(3):1057-66. PubMed ID: 18194438
[TBL] [Abstract][Full Text] [Related]
14. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects.
Sheikh KA; Sun J; Liu Y; Kawai H; Crawford TO; Proia RL; Griffin JW; Schnaar RL
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7532-7. PubMed ID: 10377449
[TBL] [Abstract][Full Text] [Related]
15. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma.
Hersey P; Jamal O; Henderson C; Zardawi I; D'Alessandro G
Int J Cancer; 1988 Mar; 41(3):336-43. PubMed ID: 3346097
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of 0-series gangliosides in human cancer cell lines with monoclonal antibodies generated using knockout mice of ganglioside synthase genes.
Bhuiyan RH; Kondo Y; Yamaguchi T; Tokuda N; Ohkawa Y; Hashimoto N; Ohmi Y; Yamauchi Y; Furukawa K; Okajima T; Furukawa K
Glycobiology; 2016 Sep; 26(9):984-998. PubMed ID: 27102283
[TBL] [Abstract][Full Text] [Related]
17. Enhanced insulin sensitivity in mice lacking ganglioside GM3.
Yamashita T; Hashiramoto A; Haluzik M; Mizukami H; Beck S; Norton A; Kono M; Tsuji S; Daniotti JL; Werth N; Sandhoff R; Sandhoff K; Proia RL
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3445-9. PubMed ID: 12629211
[TBL] [Abstract][Full Text] [Related]
18. Identification of a new liver-specific c-type mRNA transcriptional variant for mouse ST3GAL5 (GM3/GM4 synthase).
Shishido F; Uemura S; Nitta T; Inokuchi JI
Glycoconj J; 2017 Oct; 34(5):651-659. PubMed ID: 28808804
[TBL] [Abstract][Full Text] [Related]
19. GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.
Li H; Turley SD; Liu B; Repa JJ; Dietschy JM
J Lipid Res; 2008 Aug; 49(8):1816-28. PubMed ID: 18450647
[TBL] [Abstract][Full Text] [Related]
20. Beta1,4-N-acetylgalactosaminyltransferase--GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides.
Furukawa K; Takamiya K; Furukawa K
Biochim Biophys Acta; 2002 Dec; 1573(3):356-62. PubMed ID: 12417418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]